Suppr超能文献

实验性变应性脑脊髓炎的预防与抑制解释

An explanation of prevention and suppression of experimental allergic encephalomyelitis.

作者信息

Westall F C, Root-Bernstein R S

出版信息

Mol Immunol. 1983 Feb;20(2):169-77. doi: 10.1016/0161-5890(83)90128-1.

Abstract

An explanation of experimental allergic encephalomyelitis prevention and suppression is presented based upon evidence that the active unit in disease induction is an encephalitogen-adjuvant complex. The stereochemical complementarity in structure of the encephalitogen and adjuvant is mirrored in complementarity in the recognition sites of lymphocyte populations activated against encephalitogen and adjuvant. Since two complementary lymphocyte populations are necessary for disease induction, any procedure that prevents the development of one of these populations will prevent disease induction. Any procedure that eliminates one population after induction has occurred will suppress the disease. We argue that all extant data support the hypothesis. Several new experiments are proposed to further test it.

摘要

基于疾病诱导中的活性单位是脑脊髓炎原-佐剂复合物这一证据,对实验性变应性脑脊髓炎的预防和抑制进行了解释。脑脊髓炎原和佐剂结构上的立体化学互补性反映在针对脑脊髓炎原和佐剂激活的淋巴细胞群体识别位点的互补性上。由于疾病诱导需要两个互补的淋巴细胞群体,任何阻止其中一个群体发育的程序都将阻止疾病诱导。在诱导发生后消除其中一个群体的任何程序都将抑制该疾病。我们认为所有现有数据都支持这一假设。还提出了几个新实验以进一步检验它。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验